<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[Should GlaxoSmithKline Pull Avandia from the Shelves?]]></title><link>http://www.bloggingstocks.com/2010/02/22/should-glaxosmithkline-pull-avandia-from-the-shelves/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2010/02/22/should-glaxosmithkline-pull-avandia-from-the-shelves/</guid><comments>http://www.bloggingstocks.com/2010/02/22/should-glaxosmithkline-pull-avandia-from-the-shelves/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/products-and-services/" rel="tag">Products and Services</a>, <a href="http://www.bloggingstocks.com/category/scandals/" rel="tag">Scandals</a></p><img hspace="4" vspace="4" align="right" alt="" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2010/02/gsk-logo-240.jpg" />According to <em>The Wall Street Journal</em>, confidential studies from the Food and Drug Administration officials show that GlaxoSmithKline's (<a href="http://www.dailyfinance.com/quotes/glaxosmithkline-plc/gsk/nys" target="_blank">GSK</a>) diabetes medicine Avandia needs to be <a href="http://online.wsj.com/article/SB10001424052748704757904575077660421044000.html?ru=MKTW&amp;mod=MKTW" target="_blank">pulled from the market because it is linked to heart attacks</a>. <br />
<br />
These studies were part of a bipartisan report on the diabetes drug conducted by Senate Finance Committee members Chuck Grassley (R - Iowa) and Max Baucus (D - Montana). In a statement from GSK, the company noted that it has extensively studied Avandia in more than 52,000 patients, noting that none of its reports show a "statistically significant association" between Avandia and heart attacks.<p><a href="http://www.bloggingstocks.com/2010/02/22/should-glaxosmithkline-pull-avandia-from-the-shelves/" rel="bookmark">Continue reading <em>Should GlaxoSmithKline Pull Avandia from the Shelves?</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2010/02/22/should-glaxosmithkline-pull-avandia-from-the-shelves/">Should GlaxoSmithKline Pull Avandia from the Shelves?</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Mon, 22 Feb 2010 09:30:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2010/02/22/should-glaxosmithkline-pull-avandia-from-the-shelves/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/19367760/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2010/02/22/should-glaxosmithkline-pull-avandia-from-the-shelves/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>Avandia</category><category>featured</category><category>glaxosmithkline</category><category>gsk</category><category>heart</category><category>heart attack risk</category><category>heart attacks</category><category>inthenews</category><dc:creator><![CDATA[Mark Fightmaster]]></dc:creator><pubDate>Mon, 22 Feb 2010 09:30:00 EST</pubDate></item><item><title><![CDATA[Dr. Robert Jarvik pressured for not rowing his own boat for Lipitor]]></title><link>http://www.bloggingstocks.com/2008/02/08/dr-robert-jarvik-pressured-for-not-rowing-his-own-boat-for-lipi/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2008/02/08/dr-robert-jarvik-pressured-for-not-rowing-his-own-boat-for-lipi/</guid><comments>http://www.bloggingstocks.com/2008/02/08/dr-robert-jarvik-pressured-for-not-rowing-his-own-boat-for-lipi/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/television/" rel="tag">Television</a>, <a href="http://www.bloggingstocks.com/category/rants-and-raves/" rel="tag">Rants and Raves</a>, <a href="http://www.bloggingstocks.com/category/pfe/" rel="tag">Pfizer (PFE)</a>, <a href="http://www.bloggingstocks.com/category/marketing-and-advertising/" rel="tag">Marketing and Advertising</a>, <a href="http://www.bloggingstocks.com/category/mrk/" rel="tag">Merck and Co (MRK)</a>, <a href="http://www.bloggingstocks.com/category/politics/" rel="tag">Politics</a></p><img alt="Pfizer logo" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2008/02/logo_pfizer.gif" align="right" />Talk about your tempest in a teapot, here's a good one for you. It seems that a congressional committee has taken up arms against Dr. Robert Jarvik, inventor of the artificial heart, because he didn't row his own boat in his recent appearance in a Lipitor television advertisement. The concern is over whether the doctor should be represented as rowing a boat when the person in the boat pictures isn't actually him. Next, Congress will be exposing the fact that M &amp; M's don't really talk to Santa Claus. Dang it, I hate when that happens.<br /><br />Further noise is being made because the good doctor is apparently not licensed to practice medicine. That makes some people question his worthiness to crow for Lipitor. That's funny, I don't remember him claiming that he'd prescribed the stuff to anyone himself. Does it really matter in the final analysis if the man isn't licensed to work in a hospital? Not to me. He's a doctor who knows hearts and he wants people to know how they might better care for their own. He apparently uses the product, it works for him, and he's willing to talk about it. That's kind of the basics of simple endorsement, isn't it?<br /><br />I'll tell you what I think this is all about. I think some of those good old boys in the halls of Congress probably sold short on <a href="http://finance.aol.com/quotes/pfizer-inc/pfe/nys">Pfizer Inc.</a> (NYSE: <a href="http://finance.aol.com/quotes/pfizer-inc/pfe/nys">PFE</a>) , and they're probably mad because Dr. Jarvik's endorsement isn't allowing Lipitor to be crushed by Zocor, its cheaper generic competition. You can almost see their smug bipartisan grins as you read the whole story from <a title="More Articles by Stephanie Saul" href="http://topics.nytimes.com/top/reference/timestopics/people/s/stephanie_saul/index.html?inline=nyt-per">Stephanie Saul</a> in <em><a href="http://www.nytimes.com/2008/02/07/business/media/07jarvik.html?pagewanted=1&amp;_r=1&amp;ref=business">The New York Times</a></em>. I think they want to muddy the waters just long enough for their short bets to come in, regardless of the cost to Dr. Jarvik's reputation. Those Washington stuffed shirts sure got their committees all whipped up in a big hurry on this one, didn't they. That's kind of telling, isn't it.<br /><br />I suppose next they'll be telling us that geckos don't really talk about car insurance. Could that even be possible?<p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2008/02/08/dr-robert-jarvik-pressured-for-not-rowing-his-own-boat-for-lipi/">Dr. Robert Jarvik pressured for not rowing his own boat for Lipitor</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Fri, 08 Feb 2008 10:05:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href=http://www.nytimes.com/2008/02/07/business/media/07jarvik.html?pagewanted=1&amp;_r=1&amp;ref=business>Read</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2008/02/08/dr-robert-jarvik-pressured-for-not-rowing-his-own-boat-for-lipi/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/1109909/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2008/02/08/dr-robert-jarvik-pressured-for-not-rowing-his-own-boat-for-lipi/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>artificial heart</category><category>ArtificialHeart</category><category>boat</category><category>cholesterol</category><category>Dr. Robert Jarvik</category><category>Dr.RobertJarvik</category><category>featured</category><category>health</category><category>heart</category><category>Jarvik</category><category>Lipitor</category><category>Pfizer</category><category>rowing</category><category>sculling</category><category>Zocor</category><dc:creator><![CDATA[Gary Sattler]]></dc:creator><pubDate>Fri, 08 Feb 2008 10:05:00 EST</pubDate></item><item><title><![CDATA[Pfizer is up off the mat -- now is the time to move]]></title><link>http://www.bloggingstocks.com/2007/03/22/pfizer-is-up-off-the-mat-now-is-the-time-to-move/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2007/03/22/pfizer-is-up-off-the-mat-now-is-the-time-to-move/</guid><comments>http://www.bloggingstocks.com/2007/03/22/pfizer-is-up-off-the-mat-now-is-the-time-to-move/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/good-news/" rel="tag">Good news</a>, <a href="http://www.bloggingstocks.com/category/products-and-services/" rel="tag">Products and Services</a>, <a href="http://www.bloggingstocks.com/category/competitive-strategy/" rel="tag">Competitive Strategy</a>, <a href="http://www.bloggingstocks.com/category/pfe/" rel="tag">Pfizer (PFE)</a></p><p>No doubt by now you have heard the <a href="http://www.nytimes.com/2007/03/21/business/21generic.html?_r=1&amp;oref=slogin">good news</a> regarding Pfizer Inc. (NYSE:<a href="http://finance.aol.com/quotes/pfe/nys">PFE</a>) and the shield it has in place for <em>Celebrex</em>. You can get some more insight on that by reading Douglas McIntyre's <a href="http://www.bloggingstocks.com/2007/03/21/pfizer-finally-beats-back-the-generics-for-now/">post</a>.</p>
<p>Now the time is ripe for Pfizer to do something powerful. If it can accomplish one or two block buster product releases before mid-year, it'll be off to the races once again. In pursuit of that goal, Pfizer has a large stable of potential ground shakers in development. Here's an encapsulated view of what Pfizer has going right now in R&amp;D:</p>
<p>I counted 49 formulations that Pfizer has in <a href="http://www.pfizer.com/pfizer/help/download/index_pipeline.jsp?page=2">PHASE I</a> of development. Of those compounds, ten are intended cancer treatments, eight are for inflammation and / or pain, including arthritis, 11 are directed towards cardiology, metabolic and endocrine conditions. Pfizer also has six compounds in PHASE I that are indicated for infectious diseases. Phase one drug testing focuses on compound safety rather than drug effectiveness.</p><p><a href="http://www.bloggingstocks.com/2007/03/22/pfizer-is-up-off-the-mat-now-is-the-time-to-move/" rel="bookmark">Continue reading <em>Pfizer is up off the mat -- now is the time to move</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2007/03/22/pfizer-is-up-off-the-mat-now-is-the-time-to-move/">Pfizer is up off the mat -- now is the time to move</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Thu, 22 Mar 2007 10:34:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href=http://www.nytimes.com/2007/03/21/business/21generic.html?_r=1&amp;oref=slogin>Read</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2007/03/22/pfizer-is-up-off-the-mat-now-is-the-time-to-move/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/857966/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2007/03/22/pfizer-is-up-off-the-mat-now-is-the-time-to-move/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>approved</category><category>arthritis</category><category>cancer</category><category>cardio</category><category>cardiovascular</category><category>drug</category><category>epilepsy</category><category>fibromyalgia</category><category>heart</category><category>HIV</category><category>I</category><category>II</category><category>III</category><category>malaria</category><category>medication</category><category>obesity</category><category>pfe</category><category>Pfizer</category><category>phase</category><category>registered</category><category>treatment</category><dc:creator><![CDATA[Gary Sattler]]></dc:creator><pubDate>Thu, 22 Mar 2007 10:34:00 EST</pubDate></item><item><title><![CDATA[If you have to sin -- go for the Big One!!]]></title><link>http://www.bloggingstocks.com/2007/03/03/if-you-have-to-sin-go-for-the-big-one/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2007/03/03/if-you-have-to-sin-go-for-the-big-one/</guid><comments>http://www.bloggingstocks.com/2007/03/03/if-you-have-to-sin-go-for-the-big-one/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/internet/" rel="tag">Internet</a>, <a href="http://www.bloggingstocks.com/category/blogs/" rel="tag">Blogs</a>, <a href="http://www.bloggingstocks.com/category/nextbigthing/" rel="tag">Next Big Thing</a>, <a href="http://www.bloggingstocks.com/category/columns/" rel="tag">Columns</a>, <a href="http://www.bloggingstocks.com/category/books/" rel="tag">Books</a></p><img vspace="4" hspace="4" border="0" align="right" alt="don't eat your veggies"  src="http://www.blogcdn.com/www.bloggingstocks.com/media/2007/03/healthy_veggies.jpg" />Okay, let me think here for a moment, I have had a tough week in the stock market; something about issues in <a href="http://www.bloggingstocks.com/category/china/">China</a> that started it all. Oh well, people saw a dip in their savings and net worth this week... but hey, I feel good. After all I have no plans to go to China or even eat Chinese tonight. I actually feel great because let's see... Monday , I ate organically-raised salmon with a few raw vegetables!! Tuesday and Wednesday I had different variations of broiled chicken with a couple of different sauces... I am so wicked. The fresh veggies were accompanied with rice -- healthy brown rice of course. Man, I am good... following this health regime like a trooper. My doctor is going to be so proud of me! I've lost 4 pounds in 3 weeks... gimme more veggies, green, yellow, red... love em all!!
<p>I snacked on carrot sticks Tuesday and Wednesday evening and feeling a bit naughty, I even added an herb dip on Wednesday... man, I am going to become patient-of-the-week. Thursday was the <em>coup de gras</em> or whatever it is the French say -- I had baked trout, with lemon juice on the side, of course, and a baked potato, no butter, no chives, just low-fat sour cream. I had a high-fiber breakfast cereal every day this week... so who cares about the stock market's bad week, I had fantastic returns from eating right and feeling good. Those old jeans aren't so snug anymore!!</p>
<p>Friday evening... let's see, the chicken looks boring, the trout and salmon look and taste like cardboard -- I have had it!! I am going to splurge and the doctors and nurses can kiss my $%^&amp;&amp;... <a href="http://smallbusiness.aol.com/start/startup/article/_a/cashing-in-on-controversy/20070301164709990001">off I go to "Heart Attack Grill"!!</a></p><p><a href="http://www.bloggingstocks.com/2007/03/03/if-you-have-to-sin-go-for-the-big-one/" rel="bookmark">Continue reading <em>If you have to sin -- go for the Big One!!</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2007/03/03/if-you-have-to-sin-go-for-the-big-one/">If you have to sin -- go for the Big One!!</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Sat, 03 Mar 2007 11:38:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2007/03/03/if-you-have-to-sin-go-for-the-big-one/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/844550/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2007/03/03/if-you-have-to-sin-go-for-the-big-one/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>attack</category><category>burgers</category><category>fast food</category><category>FastFood</category><category>grill</category><category>healthy</category><category>heart</category><category>heart attack grill</category><category>HeartAttackGrill</category><category>tempe</category><dc:creator><![CDATA[Georges Yared]]></dc:creator><pubDate>Sat, 03 Mar 2007 11:38:00 EST</pubDate></item><item><title><![CDATA[Daily option update - January 30, 2007]]></title><link>http://www.bloggingstocks.com/2007/01/30/daily-option-update-january-30-2007/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2007/01/30/daily-option-update-january-30-2007/</guid><comments>http://www.bloggingstocks.com/2007/01/30/daily-option-update-january-30-2007/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/major-movement/" rel="tag">Major Movement</a>, <a href="http://www.bloggingstocks.com/category/aapl/" rel="tag">Apple Inc (AAPL)</a>, <a href="http://www.bloggingstocks.com/category/mot/" rel="tag">Motorola (MOT)</a>, <a href="http://www.bloggingstocks.com/category/cat/" rel="tag">Caterpillar (CAT)</a>, <a href="http://www.bloggingstocks.com/category/cfc/" rel="tag">Countrywide Financial (CFC)</a>, <a href="http://www.bloggingstocks.com/category/x/" rel="tag">U.S. Steel (X)</a>, <a href="http://www.bloggingstocks.com/category/options/" rel="tag">Options</a></p><p><a href="http://www.theflyonthewall.com/splashPage.php?source=AOL "><img align="right" alt="" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2007/01/flywall_final_logo_mini.gif" /></a><em>Note: The Daily Option Update is provided by Options Specialist Paul Foster of theflyonthewall.com.</em></p>
<p>Volatility Index S&amp;P 500 Options-VIX down .35 to 11.10.</p>
<p><strong>AtheroGenics Inc. </strong>(NASDAQ:<a href="http://finance.aol.com/quotes/atherogenics-inc/agix/nas">AGIX</a>) derivatives high risk, option volume up traders prepare for data. AtheroGenics focuses on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases. AtheroGenics is expected to announce results for top line data from the ARISE Phase 3 trial on AGI-1067 (coronary heart disease treatment.) AGIX said on 1/8/07 the data "will likely be available no sooner than late first quarter." AtheroGenics call option volume of 27,881 contracts compares to put volume of 14,119 contracts. AtheroGenics April 12.5 straddle is at $11 dollars, according to Track Data, suggesting large risks.</p>
<p>Option volume leaders today were: Motorola Inc. (NYSE:<a href="http://finance.aol.com/quotes/motorola-inc/mot/nys">MOT</a>), Apple, Inc.(NASDAQ:<a href="http://finance.aol.com/quotes/apple-inc/aapl/nas">AAPL</a>), CountryWide Financial Corp. (NYSE:<a href="http://finance.aol.com/quotes/countrywide-financial-corporation/cfc/nys">CFC</a>), Caterpillar Inc. (NYSE:<a href="http://finance.aol.com/quotes/caterpillar-inc/cat/nys">CAT</a>) and U.S. Steel Corp. (NYSE:<a href="http://finance.aol.com/quotes/united-states-steel-corporation/x/nys">X</a>).</p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2007/01/30/daily-option-update-january-30-2007/">Daily option update - January 30, 2007</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Tue, 30 Jan 2007 16:10:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2007/01/30/daily-option-update-january-30-2007/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/745262/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2007/01/30/daily-option-update-january-30-2007/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>AGIX</category><category>Apple</category><category>ARISE</category><category>Athero Genics</category><category>AtheroGenics</category><category>cardiac</category><category>cat</category><category>cfc</category><category>deriviatives</category><category>FDA</category><category>Heart</category><category>icahn</category><category>mot</category><category>options</category><category>phase</category><category>risk</category><category>Traders</category><category>US Steel</category><category>UsSteel</category><category>x</category><dc:creator><![CDATA[Paul Foster]]></dc:creator><pubDate>Tue, 30 Jan 2007 16:10:00 EST</pubDate></item></channel></rss>
